Schellhammer Urological Research Foundation
Today's Research Offers Tomorrow's Hope
Home
Welcome Clinicians
About Us
Newsletters
Events
Patient Information
Links
Publications
Areas of Urology and REsearch
Current NEWSLETTER
 
OUR NAME AND OUR MISSION HAS GROWN
The byline Schellhammer Urological Research Foundationhas been added to the familiar and long held identifier Virginia Prostate Center (VPC).  Our clinical and basic science research in the field of prostate cancer diagnosis and treatment has expanded with each passing year and will continue to do so.  Prostate cancer is the most common malignancy diagnosed in men.  However, two other urologic cancers - kidney cancer and bladder cancer - are responsible for significant mortality in both men and women.  The critical mass of clinicians and basic scientists has grown so as to allow direction of our efforts to provide many of the tools that have been developed to address the diagnosis and treatment of prostate cancer to these malignancies as well.  As an example, we have entered a collaborative effort to establish a SPORE (Specialized Program Of Research Excellence) with the University of Virginia Medical Center in Charlottesville.

Our intent and hope is that the Schellhammer Urological Research Foundation will provide a wellspring of support for improving the quality and quantity of life of patients with urologic cancer as well as benign diseases of the urinary system.

Schellhammer Urological Research Foundation Newsletters

Volume 1 No 1 - Summer 2017